India vs Peru: Proportion of isolates with decreased susceptibility or resistance
India
0
in 2020
Peru
0
in 2020
India rank
13th
Peru rank
13th
Proportion of isolates with decreased susceptibility or resistance over time
- India
- Peru
How they compare
India currently reports 0 against 0 in Peru, a difference of 0.
The two have swapped places 3 times across 7 shared years of data; in 2009 it was India ahead.
India ranks 13th and Peru ranks 13th of 52 countries.
India has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | India | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.81 | 0 | 10.81 | India |
| 2010s | 3.9 | 0.4762 | 3.43 | India |
| 2020s | 0 | 0 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, India or Peru?
- India, at 0 against 0 in Peru as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between India and Peru?
- 0, with India ahead.
- How many years of comparable data are there for India and Peru?
- 7 years are reported by both, from 2009 to 2020.
- How do India and Peru rank globally for proportion of isolates with decreased susceptibility or resistance?
- India ranks 13th and Peru ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.